Biosenta Announces Successful Launch of Bench Scale Production Plant and Exceeding Expectations of Tri-Filler(TM) Particle Encapsulation Technology
Biosenta Announces Successful Launch of Bench Scale Production Plant and Exceeding Expectations of Tri-Filler(TM) Particle Encapsulation Technology
Toronto, Ontario and Calgary, Alberta--(Newsfile Corp. - March 27, 2024) - Biosenta Inc. (CSE: ZRO) ("Biosenta" or the "Company") is pleased to announce a significant milestone in its technological and operational advancements with the successful construction and operation of a bench scale production plant. The results from this production not only surpassed our expectations, but also showcased that our patented Tri-Filler antimicrobial technology is ready for accelerated development and scaling towards industrial manufacturing applications.
安大略省多伦多和艾伯塔省卡尔加里--(Newsfile Corp.,2024年3月27日)——Biosenta Inc.(CSE:ZRO)(“Biosenta” 或 “公司”)很高兴地宣布,成功建造和运营了一座台式生产工厂,这是其技术和运营进步的一个重要里程碑。此次生产的结果不仅超出了我们的预期,而且表明我们的专利Tri-Filler抗菌技术已准备就绪,可以加速开发并扩展到工业制造应用。
Operational Success and Optimizations
运营成功与优化
Biosenta has successfully constructed and commenced operations of a bench scale production plant, showcasing our capability to produce up to 15 kilograms of Tri-Filler daily. This marks a significant scale-up from our previous capacity, which was limited to smaller quantities for lab testing purposes only.
Biosenta 已成功建造并开始运营一座台式生产工厂,展示了我们每天生产多达 15 千克的 Tri-Filler 的能力。这标志着我们以前的产能大幅扩大,以前的产能仅限于较小的数量,仅用于实验室测试目的。
CEO's Perspective
首席执行官的观点
"This is an amazing achievement by Dr. Maen Husein and group. The optimized particles are now being tested in industrial manufacturing processes," says Am Gill, CEO of Biosenta Inc. This development is not just a step forward in antimicrobial technology but also a testament to our team's dedication and innovative spirit.
“这是Maen Husein博士及其团队取得的一项了不起的成就。经过优化的颗粒现在正在工业制造过程中进行测试,” Biosenta Inc.首席执行官阿姆·吉尔说。这一发展不仅是抗菌技术向前迈出的一步,也是我们团队的奉献精神和创新精神的见证。
Promising Results and Future Directions
令人鼓舞的结果和未来方向
According to Dr. Maen Husein, "The initial runs of Tri-Filler have delivered beyond expectations, with particle quality surpassing pre-established benchmarks. These results validate both the antimicrobial efficacy of the particles and the design of the manufacturing unit." Next steps involve operation of the bench scale plant, aiming to produce sufficient Tri-Filler for pilot runs in various industrial processes such as coatings, concrete, drywall, plastics, and other vast materials in the construction industry. Plans for a commercial scale plant will follow.
根据梅恩·侯赛因博士的说法, “Tri-Filler 的初始运行效果超出了预期,颗粒质量超过了预先设定的基准。这些结果验证了颗粒的抗微生物功效和制造单元的设计。” 接下来的步骤涉及台秤工厂的运营,目标是生产足够的三填充物,用于建筑行业中涂料、混凝土、石膏板、塑料和其他大型材料等各种工业过程的试运行。随后将计划建造一座商业规模的工厂。
Research Collaboration with the University of Calgary
与卡尔加里大学的研究合作
In partnership with the University of Calgary, further investigations will assess the performance of the bench scale plant against diverse input grades. This collaboration is crucial for refining the industrial scale plant's optimization, paving the way for broader commercial applications of Tri-Filler technology.
与卡尔加里大学合作,进一步的调查将根据不同的投入等级评估该台秤工厂的性能。这种合作对于完善工业规模工厂的优化至关重要,为Tri-Filler技术的更广泛商业应用铺平了道路。
Looking Ahead
展望未来
The construction of an industrial scaleup plant is under active consideration, with further details and timelines to be shared. This move will significantly enhance our production capabilities and impact across multiple industries.
正在积极考虑建造工业规模化工厂,更多细节和时间表有待分享。此举将显著增强我们的生产能力和对多个行业的影响。
About Biosenta Inc.
关于 Biosenta Inc.
Biosenta Inc. is dedicated to the discovery, development, and commercialization of innovative antimicrobial products derived from its proprietary Tri-Filler technology. Based in Toronto, Ontario, Biosenta aims to revolutionize the way we combat microbes, offering solutions that are not only effective but also environmentally friendly and sustainable.
Biosenta Inc. 致力于发现、开发和商业化源自其专有Tri-Filler技术的创新抗菌产品。Biosenta总部位于安大略省多伦多,旨在彻底改变我们对抗微生物的方式,提供不仅有效而且环保和可持续的解决方案。
For further inquiries, please contact:
如需进一步查询,请联系:
Am Gill, President and CEO, Biosenta Inc.
Email: info@biosenta.com
Phone: 416-410-2019
Am Gill,Biosenta Inc. 总裁兼首席执行官
电子邮件:info@biosenta.com
电话:416-410-2019
Biosenta is poised for a future where our antimicrobial technology plays a pivotal role in promoting public health and safety. Stay tuned for more updates as we continue to innovate and expand our reach.
Biosenta已为我们的抗菌技术在促进公共健康和安全方面发挥关键作用的未来做好了准备。在我们继续创新和扩大覆盖范围的同时,请继续关注更多更新。
Forward-Looking Statements
前瞻性陈述
This press release contains forward-looking statements. Readers are cautioned that such statements are only predictions and involve risks and uncertainties that could cause actual events or results to differ materially.
本新闻稿包含前瞻性陈述。请读者注意,此类陈述只是预测,涉及风险和不确定性,可能导致实际事件或结果出现重大差异。
For more information, visit our website:
欲了解更多信息,请访问我们的网站: